aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Gritstone bio, Inc., founded in August 2015 and based in Emeryville, California, is a clinical-stage American biotechnology company. Its core mission is to develop groundbreaking immunotherapies for cancers and infectious diseases by leveraging the natural power of a patient’s immune system. The company focuses on generating therapeutic immune responses to recognize and destroy tumors or virally infected cells. Gritstone bio offers cancer care drugs and is also developing vaccines, including a second-generation SARS-CoV-2 vaccine.
Notable affiliated individuals include its founders and key scientific advisors, who are leaders in oncology and immunotherapy. In September 2021, Gritstone bio raised $55 million from the sale of 5,000,000 shares, highlighting strong investor confidence. The company has initiated several clinical trials, including a Phase 1 trial for its self-amplifying mRNA SARS-CoV-2 vaccine. Gritstone bio's innovative approach has the potential to significantly impact cancer treatment and infectious disease management, positioning it as a pioneering force in the biotech industry.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Cancer Drugs, Vaccines
Technology
Biotech
Tags
Healthtech
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Gritstone bio founded?
Gritstone bio was founded in 2015.
Where is Gritstone bio's headquarters located?
Gritstone bio's headquarters is located in Emeryville, CA, US.
When was Gritstone bio's last funding round?
Gritstone bio's most recent funding round was for $80M (USD) in July 2022.
How many employees does Gritstone bio have?
Gritstone bio has 233 employees as of Feb 6, 2024.
How much has Gritstone bio raised to-date?
As of July 05, 2023, Gritstone bio has raised a total of $571.6M (USD) since Jul 22, 2022.
Add Comparison
Total Raised to Date
$571.6M
USD
Last Update Jul 22, 2022
Last Deal Details
$80M
USD
Jul 22, 2022
Post Ipo Debt
Total Employees Over Time
233
As of Feb 2024
Gritstone bio Address
5858 Horton St
Emeryville,
California
94608
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts